These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38108460)

  • 41. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Sahin Y; Unluhizarci K; Yilmazsoy A; Yikilmaz A; Aygen E; Kelestimur F
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L; Pasinetti E
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Role of hyperinsulinemia in pathogenesis of polycystic ovary syndrome and treatment by reduction of insulin secretion].
    Wang A; Li M; Lu C
    Zhonghua Fu Chan Ke Za Zhi; 1998 Dec; 33(12):731-4. PubMed ID: 10806662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Polycystic ovary syndrome: treatment with insulin-sensitizing agents].
    Laboureau-Soares Barbosa S; Rodien P; Rohmer V
    Ann Endocrinol (Paris); 2002 Feb; 63(1):31-5. PubMed ID: 11937980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses.
    Teede H; Tassone EC; Piltonen T; Malhotra J; Mol BW; Peña A; Witchel SF; Joham A; McAllister V; Romualdi D; Thondan M; Costello M; Misso ML
    Clin Endocrinol (Oxf); 2019 Oct; 91(4):479-489. PubMed ID: 31087796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of metformin in the treatment of polycystic ovary syndrome (PCOS).
    Wang HS
    Chang Gung Med J; 2006; 29(5):445-7. PubMed ID: 17214387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire.
    Conway G; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Franks S; Gambineri A; Kelestimur F; Macut D; Micic D; Pasquali R; Pfeifer M; Pignatelli D; Pugeat M; Yildiz B;
    Eur J Endocrinol; 2014 Oct; 171(4):489-98. PubMed ID: 25049203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sustained Maternal Hyperandrogenism During PCOS Pregnancy Reduced by Metformin in Non-obese Women Carrying a Male Fetus.
    Andræ F; Abbott D; Stridsklev S; Schmedes AV; Odsæter IH; Vanky E; Salvesen Ø
    J Clin Endocrinol Metab; 2020 Dec; 105(12):3762-70. PubMed ID: 32866967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
    Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
    Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
    Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment.
    Heutling D; Schulz H; Nickel I; Kleinstein J; Kaltwasser P; Westphal S; Mittermayer F; Wolzt M; Krzyzanowska K; Randeva H; Schernthaner G; Lehnert H
    J Clin Endocrinol Metab; 2008 Jan; 93(1):82-90. PubMed ID: 17986642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
    Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome.
    Banaszewska B; Pawelczyk L; Spaczynski R
    Reprod Biol; 2019 Dec; 19(4):309-315. PubMed ID: 31606349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial.
    Kuek S; Wang WJ; Gui SQ
    Zhong Xi Yi Jie He Xue Bao; 2011 Sep; 9(9):965-72. PubMed ID: 21906521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statins for women with polycystic ovary syndrome not actively trying to conceive.
    Raval AD; Hunter T; Stuckey B; Hart RJ
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008565. PubMed ID: 21975784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
    Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Macedo CR
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006105. PubMed ID: 25406011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Off-label drug use in the treatment of polycystic ovary syndrome.
    Vitek W; Alur S; Hoeger KM
    Fertil Steril; 2015 Mar; 103(3):605-11. PubMed ID: 25726702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial.
    Alpañés M; Álvarez-Blasco F; Fernández-Durán E; Luque-Ramírez M; Escobar-Morreale HF
    Eur J Endocrinol; 2017 Nov; 177(5):399-408. PubMed ID: 28912358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.